JPWO2021095874A1 - - Google Patents

Info

Publication number
JPWO2021095874A1
JPWO2021095874A1 JP2021556191A JP2021556191A JPWO2021095874A1 JP WO2021095874 A1 JPWO2021095874 A1 JP WO2021095874A1 JP 2021556191 A JP2021556191 A JP 2021556191A JP 2021556191 A JP2021556191 A JP 2021556191A JP WO2021095874 A1 JPWO2021095874 A1 JP WO2021095874A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021556191A
Other languages
Japanese (ja)
Other versions
JP7689078B2 (ja
JPWO2021095874A5 (https=
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021095874A1 publication Critical patent/JPWO2021095874A1/ja
Publication of JPWO2021095874A5 publication Critical patent/JPWO2021095874A5/ja
Priority to JP2025087141A priority Critical patent/JP2025128175A/ja
Application granted granted Critical
Publication of JP7689078B2 publication Critical patent/JP7689078B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
JP2021556191A 2019-11-13 2020-11-13 オリゴ核酸化合物の製造方法 Active JP7689078B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025087141A JP2025128175A (ja) 2019-11-13 2025-05-26 オリゴ核酸化合物の製造方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019205625 2019-11-13
JP2019205625 2019-11-13
PCT/JP2020/042505 WO2021095874A1 (ja) 2019-11-13 2020-11-13 オリゴ核酸化合物の製造方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025087141A Division JP2025128175A (ja) 2019-11-13 2025-05-26 オリゴ核酸化合物の製造方法

Publications (3)

Publication Number Publication Date
JPWO2021095874A1 true JPWO2021095874A1 (https=) 2021-05-20
JPWO2021095874A5 JPWO2021095874A5 (https=) 2023-11-16
JP7689078B2 JP7689078B2 (ja) 2025-06-05

Family

ID=75913043

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021556191A Active JP7689078B2 (ja) 2019-11-13 2020-11-13 オリゴ核酸化合物の製造方法
JP2025087141A Pending JP2025128175A (ja) 2019-11-13 2025-05-26 オリゴ核酸化合物の製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025087141A Pending JP2025128175A (ja) 2019-11-13 2025-05-26 オリゴ核酸化合物の製造方法

Country Status (7)

Country Link
US (1) US12600743B2 (https=)
EP (1) EP4059944A4 (https=)
JP (2) JP7689078B2 (https=)
KR (1) KR20220098217A (https=)
CN (1) CN114981281A (https=)
CA (1) CA3161586A1 (https=)
WO (1) WO2021095874A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240254158A1 (en) * 2021-04-28 2024-08-01 Nippon Shinyaku Co., Ltd. Method for producing oligonucleic acid compound
CA3244382A1 (en) * 2021-12-27 2025-02-26 Nippon Shinyaku Co., Ltd. PROCESS FOR THE PRODUCTION OF OLIGONUCLEIC ACID COMPOUNDS

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1180185A (ja) * 1997-09-05 1999-03-26 Res Dev Corp Of Japan オリゴヌクレオチドの化学合成法
JP2002517404A (ja) * 1998-06-02 2002-06-18 アイシス・ファーマシューティカルス・インコーポレーテッド オリゴヌクレオチド合成のためのアクチベーター
WO2003006475A2 (en) * 2001-07-12 2003-01-23 Santaris Pharma A/S Method for preparation of lna phosphoramidites
JP2010527945A (ja) * 2007-05-22 2010-08-19 ギリンデュス アクチェンゲゼルシャフト オリゴヌクレオチドの合成

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2130844A5 (https=) 1971-03-23 1972-11-10 Commissariat Energie Atomique
JPS5668388A (en) 1979-11-10 1981-06-09 Norin Suisansyo Shokuhin Sogo Kenkyusho Production of cell body of spirulina algae
JP3398378B2 (ja) 1989-12-20 2003-04-21 アンチビラルス・インコーポレイテツド リン含有キラルインターサブユニットリンケージを有する非電荷モルホリノ―基体ポリマー
JPH10109994A (ja) * 1996-10-03 1998-04-28 Sumitomo Chem Co Ltd アミドチオリン酸エステル誘導体の製造方法
US6313301B1 (en) 1997-08-13 2001-11-06 Takeda Chemical Industries, Ltd. Thienopyridine derivatives, their intermediates and production thereof
JP2005529957A (ja) 2002-06-13 2005-10-06 ローディア インク. リン・ジアミダイト合成物を生成する工程
US8067571B2 (en) * 2005-07-13 2011-11-29 Avi Biopharma, Inc. Antibacterial antisense oligonucleotide and method
KR100886139B1 (ko) 2007-11-13 2009-02-27 주식회사 삼천리제약 올리고뉴클레오타이드의 제조방법
MX2010004955A (es) 2007-11-15 2010-06-30 Avi Biopharma Inc Metodo de sintesis de oligomeros de morfolina.
JP5548852B2 (ja) 2009-05-29 2014-07-16 国立大学法人東京農工大学 疎水性基結合ヌクレオシド、疎水性基結合ヌクレオシド溶液、及び疎水性基結合オリゴヌクレオチド合成方法
RS55610B1 (sr) 2010-09-30 2017-06-30 Nippon Shinyaku Co Ltd Derivat morfolino nukleinske kiseline
JP5979139B2 (ja) 2011-05-17 2016-08-24 味の素株式会社 オリゴヌクレオチドの製造方法
EA202090338A1 (ru) 2011-11-18 2021-04-30 Сарепта Терапьютикс, Инк. Функционально-модифицированные олигонуклеотиды и их субъединицы
US10066228B2 (en) 2011-11-30 2018-09-04 Sarepta Therapeutics, Inc. Oligonucleotides for treating expanded repeat diseases
EP2816053B1 (en) 2012-02-17 2021-03-24 Ajinomoto Co., Inc. Base-protected oligonucleotide
EP2921499B1 (en) 2012-11-14 2020-01-22 Takeda Pharmaceutical Company Limited Method for liquid-phase synthesis of nucleic acids
WO2014189142A1 (ja) 2013-05-24 2014-11-27 味の素株式会社 モルフォリノオリゴヌクレオチドの製造方法
JP6673211B2 (ja) 2014-10-14 2020-03-25 味の素株式会社 モルフォリノオリゴヌクレオチドの製造方法
EP3266792B1 (en) 2015-03-04 2020-12-30 Jitsubo Co., Ltd. Peptide synthesis method
EP3672601B1 (en) * 2017-09-25 2023-09-13 Sarepta Therapeutics, Inc. Processes for preparing phosphorodiamidate morpholino oligomers via fast-flow synthesis
CN112384520B (zh) * 2018-05-10 2024-06-11 日本新药株式会社 寡核苷酸化合物的制造方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1180185A (ja) * 1997-09-05 1999-03-26 Res Dev Corp Of Japan オリゴヌクレオチドの化学合成法
JP2002517404A (ja) * 1998-06-02 2002-06-18 アイシス・ファーマシューティカルス・インコーポレーテッド オリゴヌクレオチド合成のためのアクチベーター
WO2003006475A2 (en) * 2001-07-12 2003-01-23 Santaris Pharma A/S Method for preparation of lna phosphoramidites
JP2010527945A (ja) * 2007-05-22 2010-08-19 ギリンデュス アクチェンゲゼルシャフト オリゴヌクレオチドの合成

Also Published As

Publication number Publication date
JP2025128175A (ja) 2025-09-02
EP4059944A4 (en) 2024-04-10
US12600743B2 (en) 2026-04-14
US20230018780A1 (en) 2023-01-19
CN114981281A (zh) 2022-08-30
JP7689078B2 (ja) 2025-06-05
WO2021095874A1 (ja) 2021-05-20
CA3161586A1 (en) 2021-05-20
EP4059944A1 (en) 2022-09-21
KR20220098217A (ko) 2022-07-11

Similar Documents

Publication Publication Date Title
BR112019017762A2 (https=)
BR112021017339A2 (https=)
BR112021018450A2 (https=)
BR112021017637A2 (https=)
BR112021017892A2 (https=)
BR112021017782A2 (https=)
BR112021016821A2 (https=)
BR112021017939A2 (https=)
BR112021017738A2 (https=)
BR112021016996A2 (https=)
BR112021008711A2 (https=)
BR112019016141A2 (https=)
BR112021017728A2 (https=)
AU2020104490A5 (https=)
BR112021013944A2 (https=)
BR112021018452A2 (https=)
BR112021017703A2 (https=)
BR112021018102A2 (https=)
BR112019016142A2 (https=)
BR112019016138A2 (https=)
BR112021017732A2 (https=)
BR112021017234A2 (https=)
BR112021017355A2 (https=)
BR112021018168A2 (https=)
BR112021018093A2 (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231108

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20231108

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241112

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250110

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250214

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250430

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250526

R150 Certificate of patent or registration of utility model

Ref document number: 7689078

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150